Source link : https://www.mondialnews.com/2026/05/02/opioid-maker-purdue-pharma-closes-doors-after-7-4-billion-settlement/
Purdue Pharma, the pharmaceutical company long at the center of the nation’s opioid crisis, has announced it will shut down operations as part of a landmark $7.4 billion settlement agreement. The move marks a significant turning point in the ongoing legal battles surrounding the company’s role in the widespread opioid epidemic that has claimed hundreds of thousands of lives across the United States. Under the terms of the deal, Purdue Pharma will cease to exist in its current form, with the settlement funds aimed at supporting addiction treatment and prevention efforts nationwide.
Purdue Pharma Closure Marks Major Shift in Opioid Litigation Landscape
Purdue Pharma’s decision to cease operations comes as a landmark development in the battle against the opioid crisis that has devastated communities across the United States. The closure accompanies a historic $7.4 billion settlement aimed at addressing the company’s role in fueling widespread addiction through aggressive marketing of its painkiller OxyContin. This move is expected to unlock significant resources for addiction treatment, prevention programs, and victim compensation, reshaping the way pharmaceutical accountability is handled in future litigation.
Key elements of the agreement include:
- Establishment of a public benefit trust funded by the settlement to support addiction recovery efforts nationwide.
- Structural changes within the company, effectively ending Purdue Pharma’s role as a traditional…
—-
Author : Caleb Wilson
Publish date : 2026-05-02 04:08:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8